• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两亲性胍基杯[4]芳烃抑制脂多糖 (LPS) 和凝集素刺激的 Toll 样受体 4 (TLR4) 信号通路。

Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.

机构信息

Department of Biotechnology and Biosciences, University of Milano-Bicocca , Piazza della Scienza, 2, 20126 Milano, Italy.

Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma , Parco Area delle Scienze 17/a, 43124 Parma, Italy.

出版信息

J Med Chem. 2017 Jun 22;60(12):4882-4892. doi: 10.1021/acs.jmedchem.7b00095. Epub 2017 May 15.

DOI:10.1021/acs.jmedchem.7b00095
PMID:28471658
Abstract

We recently reported on the activity of cationic amphiphiles in inhibiting TLR4 activation and subsequent production of inflammatory cytokines in cells and in animal models. Starting from the assumption that opportunely designed cationic amphiphiles can behave as CD14/MD-2 ligands and therefore modulate the TLR4 signaling, we present here a panel of amphiphilic guanidinocalixarenes whose structure was computationally optimized to dock into MD-2 and CD14 binding sites. Some of these calixarenes were active in inhibiting, in a dose-dependent way, the LPS-stimulated TLR4 activation and TLR4-dependent cytokine production in human and mouse cells. Moreover, guanidinocalixarenes also inhibited TLR4 signaling when TLR4 was activated by a non-LPS stimulus, the plant lectin PHA. While the activity of guanidinocalixarenes in inhibiting LPS toxic action has previously been related to their capacity to bind LPS, we suggest a direct antagonist effect of calixarenes on TLR4/MD-2 dimerization, pointing at the calixarene moiety as a potential scaffold for the development of new TLR4-directed therapeutics.

摘要

我们最近报道了阳离子两亲物在抑制 TLR4 激活及其在细胞和动物模型中随后产生炎症细胞因子方面的活性。基于阳离子两亲物可以作为 CD14/MD-2 配体发挥作用并因此调节 TLR4 信号的假设,我们在此提出了一组两亲性胍基杯芳烃,其结构经过计算优化以与 MD-2 和 CD14 结合位点对接。这些杯芳烃中的一些能够以剂量依赖的方式抑制 LPS 刺激的 TLR4 激活和人源和鼠源细胞中 TLR4 依赖性细胞因子的产生。此外,当 TLR4 被植物凝集素 PHA 非 LPS 刺激激活时,胍基杯芳烃也抑制 TLR4 信号。虽然胍基杯芳烃抑制 LPS 毒性作用的活性以前与它们结合 LPS 的能力有关,但我们提出杯芳烃对 TLR4/MD-2 二聚化具有直接的拮抗作用,指出杯芳烃部分是开发新的 TLR4 导向治疗剂的潜在支架。

相似文献

1
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.两亲性胍基杯[4]芳烃抑制脂多糖 (LPS) 和凝集素刺激的 Toll 样受体 4 (TLR4) 信号通路。
J Med Chem. 2017 Jun 22;60(12):4882-4892. doi: 10.1021/acs.jmedchem.7b00095. Epub 2017 May 15.
2
Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.基于药效团的结构见解,通过计算机辅助筛选,鉴定人源 Toll 样受体 4-髓样分化因子 2(hTLR4-MD-2)复合物抑制剂。
J Biomol Struct Dyn. 2019 May;37(8):1968-1991. doi: 10.1080/07391102.2018.1474804. Epub 2018 May 29.
3
Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.甘草酸和异甘草素以不同的方式抑制 LPS 传感器 Toll 样受体 4/MD-2 复合物信号转导。
J Leukoc Biol. 2012 Jun;91(6):967-76. doi: 10.1189/jlb.0112038. Epub 2012 Mar 15.
4
The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding.阳离子两亲分子 3,4-双(十四烷氧基)苄基胺通过与内毒素竞争 CD14 结合来抑制 LPS 信号。
Biochem Pharmacol. 2010 Dec 15;80(12):2050-6. doi: 10.1016/j.bcp.2010.06.019. Epub 2010 Jun 23.
5
Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.内毒素和阿片类药物在 Toll 样受体 4 相互作用的药理学特征。
Br J Pharmacol. 2013 Mar;168(6):1421-9. doi: 10.1111/bph.12028.
6
Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface.阳离子脂质纳米载体激活Toll样受体4所涉及的关键残基并不位于脂多糖结合界面。
Cell Mol Life Sci. 2015 Oct;72(20):3971-82. doi: 10.1007/s00018-015-1915-1. Epub 2015 May 9.
7
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism.酚类1,3 - 二酮通过一种替代性的镁介导机制减轻脂多糖诱导的炎症反应。
Br J Pharmacol. 2017 May;174(10):1090-1103. doi: 10.1111/bph.13746. Epub 2017 Mar 31.
8
Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of Toll-like receptor 4 by endotoxin.苯丙氨酸121、126以及酪氨酸131在人MD-2中在内毒素激活Toll样受体4过程中的新作用。
J Biol Chem. 2008 Jan 18;283(3):1257-1266. doi: 10.1074/jbc.M705994200. Epub 2007 Oct 30.
9
Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.细胞外TLR4结构域和MD-2的重组可溶性形式可抑制脂多糖与细胞表面的结合,并减轻小鼠体内脂多糖诱导的肺部炎症。
J Immunol. 2006 Dec 1;177(11):8133-9. doi: 10.4049/jimmunol.177.11.8133.
10
Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.用二糖脂质 A 类似物定制调节细胞促炎反应。
Front Immunol. 2021 Mar 18;12:631797. doi: 10.3389/fimmu.2021.631797. eCollection 2021.

引用本文的文献

1
Antidiabetic and Immunomodulatory Properties of Peptide Fractions from Sacha Inchi Oil Press-Cake.印加果油压榨饼中肽组分的抗糖尿病和免疫调节特性
Foods. 2025 Mar 31;14(7):1231. doi: 10.3390/foods14071231.
2
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants.新型基于氨基葡萄糖的 TLR4 激动剂:设计、合成、作用机制及作为疫苗佐剂的体内活性。
J Med Chem. 2023 Feb 23;66(4):3010-3029. doi: 10.1021/acs.jmedchem.2c01998. Epub 2023 Feb 2.
3
Full-Atom Model of the Agonist LPS-Bound Toll-like Receptor 4 Dimer in a Membrane Environment.
激动剂 LPS 结合的 Toll 样受体 4 二聚体在膜环境中的全原子模型。
Chemistry. 2021 Nov 5;27(62):15406-15425. doi: 10.1002/chem.202102995. Epub 2021 Oct 12.
4
Fighting Against Bacterial Lipopolysaccharide-Caused Infections through Molecular Dynamics Simulations: A Review.通过分子动力学模拟对抗细菌脂多糖引起的感染:综述。
J Chem Inf Model. 2021 Oct 25;61(10):4839-4851. doi: 10.1021/acs.jcim.1c00613. Epub 2021 Sep 24.
5
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.TLR4 作为 SARS-CoV-2 引起的呼吸和神经系统并发症的治疗靶点。
Expert Opin Ther Targets. 2021 Jun;25(6):491-508. doi: 10.1080/14728222.2021.1918103. Epub 2021 Apr 28.
6
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview.增加基于小分子的 TLR4 调节剂的化学多样性:概述。
Front Immunol. 2020 Jul 10;11:1210. doi: 10.3389/fimmu.2020.01210. eCollection 2020.
7
Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action.合成具有抗氧化、乙酰胆碱酯酶、丁酰胆碱酯酶、酪氨酸酶和碳酸酐酶抑制活性的杯[4]氮杂冠取代磺酰胺。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1215-1223. doi: 10.1080/14756366.2020.1765166.
8
Calix[4]API-s: fully functionalized calix[4]arene-based facial active pharmaceutical ingredients.杯[4]芳烃类活性药物成分:基于杯[4]芳烃的全功能化面式活性药物成分。
Mol Divers. 2021 May;25(2):1247-1258. doi: 10.1007/s11030-020-10042-0. Epub 2020 Jan 31.
9
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties.新型羧酸酯基糖脂:TLR4 拮抗作用、MD-2 结合和自组装特性。
Sci Rep. 2019 Jan 29;9(1):919. doi: 10.1038/s41598-018-37421-w.
10
The synthesis and characterization of giant Calixarenes.巨冠醚的合成与表征。
Nat Commun. 2019 Jan 10;10(1):113. doi: 10.1038/s41467-018-07751-4.